Phenoxodiol
(Synonyms: 脱氢雌马酚,Idronoxil; Dehydroequol; Haginin E) 目录号 : GC36895
Phenoxodiol是一种异黄酮衍生物，具有抗肿瘤活性。
Cas No.:81267-65-4
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
Phenoxodiol is an isoflavone derivative with antitumor activity[1]. Phenoxodiol can induce G1 arrest in cells through p53-independent induction of p21WAF1/CIP1, resulting in loss of cyclin-dependent kinase 2 activity[2]. Phenoxodiol can induce apoptosis and target plasma membrane electron transport (PMET)[3].
In vitro, treatment of prostate cancer cell lines (LNCaP, DU145 and PC3 cells) with Phenoxodiol (10, 30μM) for 24h and 48h upregulated the expression of p21WAF1 in all cell lines and induced cell cycle arrest at the G1/S phase[4]. Pretreatment of epithelial ovarian cancer (EOC) cells with Phenoxodiol (10μg/mL) for 2h significantly reduced cell viability and enhanced the sensitivity of cells to chemotherapy[5]. Phenoxodiol (0-10μg/mL) treatment of LNCaP cells for 24h significantly inhibited cell proliferation and reduced colony formation in a dose-dependent manner[6].
In vivo, Phenoxodiol (10mg/kg) was orally treated for 16 days in mice with U2OS cell xenografts. When combined with Doxorubicin (1mg/kg, i.p.), it was able to significantly inhibit tumor growth. The tumor growth inhibition effect of the group receiving only single treatment was weak[7].
References:
[1] Choueiri T K, Wesolowski R, Mekhail T M. Phenoxodiol: isoflavone analog with antineoplastic activity[J]. Current oncology reports, 2006, 8: 104-107.
[2] Aguero M F, Facchinetti M M, Sheleg Z, et al. Phenoxodiol, a novel isoflavone, induces G1 arrest by specific loss in cyclin-dependent kinase 2 activity by p53-independent induction of p21WAF1/CIP1[J]. Cancer research, 2005, 65(8): 3364-3373.
[3] Herst P M, Petersen T, Jerram P, et al. The antiproliferative effects of phenoxodiol are associated with inhibition of plasma membrane electron transport in tumour cell lines and primary immune cells[J]. Biochemical pharmacology, 2007, 74(11): 1587-1595.
[4] Mahoney S, Arfuso F, Millward M, et al. The effects of phenoxodiol on the cell cycle of prostate cancer cell lines[J]. Cancer cell international, 2014, 14: 1-12.
[5] Alvero A B, O'Malley D, Brown D, et al. Molecular mechanism of phenoxodiol‐induced apoptosis in ovarian carcinoma cells[J]. Cancer: Interdisciplinary International Journal of the American Cancer Society, 2006, 106(3): 599-608.
[6] Yao C, Wu S, Li D, et al. Co-administration phenoxodiol with doxorubicin synergistically inhibit the activity of sphingosine kinase-1 (SphK1), a potential oncogene of osteosarcoma, to suppress osteosarcoma cell growth both in vivo and in vitro[J]. Molecular oncology, 2012, 6(4): 392-404.
[7] Aguero M F, Venero M, Brown D M, et al. Phenoxodiol inhibits growth of metastatic prostate cancer cells[J]. The Prostate, 2010, 70(11): 1211-1221.
Phenoxodiol是一种异黄酮衍生物，具有抗肿瘤活性[1]。Phenoxodiol能够通过p21WAF1/CIP1的p53独立诱导，导致周期蛋白依赖性激酶2活性的损失，从而诱导细胞G1阻滞[2]。Phenoxodiol能够引起细胞凋亡，靶向质膜电子传递（PMET）[3]。
在体外，Phenoxodiol（10, 30μM）处理前列腺癌细胞系（LNCaP、DU145和PC3细胞）24h和48h，上调了所有细胞系中p21WAF1的表达，诱导了细胞周期停滞在G1/S期[4]。Phenoxodiol（10μg/mL）预处理上皮性卵巢癌（EOC）细胞2h，显著降低了细胞活力，增强了细胞对化疗的敏感性[5]。Phenoxodiol（0-10μg/mL）处理LNCaP细胞24h，以剂量依赖性方式显著抑制了细胞的增殖，减少了集落形成[6]。
在体内，Phenoxodiol（10mg/kg）通过口服治疗U2OS细胞异种移植小鼠16天，在与Doxorubicin（1mg/kg, i.p.）联合治疗的情况下能够显著抑制肿瘤生长，仅接受单一治疗的组肿瘤生长抑制效果较弱[7]。
| Cell experiment [1]: | |
Cell lines | LNCaP、DU145、PC3 cells |
Preparation Method | Cells were cultured in vitro, and then treated with Phenoxodiol (10μM and 30μM) for 24 and 48h. The expression of cell cycle genes p21WAF1, c-Myc, Cyclin-D1, and Ki-67 was investigated by Real Time PCR. |
Reaction Conditions | 10, 30μM; 24, 48h |
Applications | Phenoxodiol induces cell cycle arrest in the G1/S phase of the cell cycle, with the resultant arrest due to the upregulation of p21WAF1 in all the cell lines in response to treatment. |
| Animal experiment [2]: | |
Animal models | CB.17 severe combined immuno-deficient (SCID) male mice |
Preparation Method | Mice was injected subcutaneously (s.c.) into the right flank with 1.5×106 U2OS cells in 0.1 ml DMEM. When the right flank xenografts were established at about 500mm3, the animals (5 mice per group) were treated daily with Doxorubicin (1mg/kg, i.p.), Phenoxodiol (10mg/kg, p.o.) or both for 16 days before sacrifice. Xenograft diameters were measured every 4 days using calipers. |
Dosage form | 10mg/kg/day for 16 days; p.o. |
Applications | Only group that received both Phenoxodiol and Doxorubicin showed a significant reduced tumor growth. The group that received either single treatment showed slight anti-tumor growth effect as compared to vehicle controls. |
References: | |
| Cas No. | 81267-65-4 | SDF | |
| 别名 | 脱氢雌马酚,Idronoxil; Dehydroequol; Haginin E | ||
| Canonical SMILES | OC1=CC=C2C=C(C3=CC=C(O)C=C3)COC2=C1 | ||
| 分子式 | C15H12O3 | 分子量 | 240.25 |
| 溶解度 | DMSO: ≥ 100 mg/mL (416.23 mM); Water: < 0.1 mg/mL (insoluble) | 储存条件 | Store at -20°C,protect from light |
| General tips | 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液；一旦配成溶液，请分装保存，避免反复冻融造成的产品失效。 储备液的保存方式和期限：-80°C 储存时，请在 6 个月内使用，-20°C 储存时，请在 1 个月内使用。 为了提高溶解度，请将管子加热至37℃，然后在超声波浴中震荡一段时间。 |
||
| Shipping Condition | 评估样品解决方案：配备蓝冰进行发货。所有其他可用尺寸：配备RT，或根据请求配备蓝冰。 | ||
| 制备储备液 | |||
 |
1 mg | 5 mg | 10 mg |
| 1 mM | 4.1623 mL | 20.8117 mL | 41.6233 mL |
| 5 mM | 0.8325 mL | 4.1623 mL | 8.3247 mL |
| 10 mM | 0.4162 mL | 2.0812 mL | 4.1623 mL |
| 第一步：请输入基本实验信息（考虑到实验过程中的损耗，建议多配一只动物的药量） | ||||||||||
| 给药剂量 | mg/kg |  |
动物平均体重 | g | |
每只动物给药体积 | ul | |
动物数量 | 只 |
| 第二步：请输入动物体内配方组成（配方适用于不溶于水的药物；不同批次药物配方比例不同，请联系GLPBIO为您提供正确的澄清溶液配方） | ||||||||||
| % DMSO % % Tween 80 % saline | ||||||||||
| 计算重置 | ||||||||||
计算结果:
工作液浓度： mg/ml；
DMSO母液配制方法： mg 药物溶于 μL DMSO溶液（母液浓度 mg/mL，
体内配方配制方法：取 μL DMSO母液，加入 μL PEG300，混匀澄清后加入μL Tween 80，混匀澄清后加入 μL saline，混匀澄清。
1. 首先保证母液是澄清的；
2.
一定要按照顺序依次将溶剂加入，进行下一步操作之前必须保证上一步操作得到的是澄清的溶液，可采用涡旋、超声或水浴加热等物理方法助溶。
3. 以上所有助溶剂都可在 GlpBio 网站选购。
Quality Control & SDS
- View current batch:
- Purity: >98.00%
- COA (Certificate Of Analysis)
- SDS (Safety Data Sheet)
- Datasheet